Douglas N Ishii from Woodland, WA, age 82

Name / Title

Company / Classification

Phones & Addresses

Douglas Ishii

Basbleu Theatre
Theatrical Producers/Services

401 Pne St, Fort Collins, CO 80524
216 Pne St, Fort Collins, CO 80524
970 498-8949

Method For Effecting Changes In The Central Nervous System By Administration Of Igf-I Or Igf-Ii
view source
US Patent:

20070078089, Apr 5, 2007
Filed:

Nov 27, 2006
Appl. No.:

11/604593
Inventors:

Douglas Ishii - LaPorte CO, US
International Classification:

A61K 38/30
US Classification:

514012000
Abstract:

The invention concerns a method for effecting changes in the central nervous system, including treatment of brain and spinal cord disorders or diseases, by parenteral administration of insulin-like growth factors I (IGF-I) or insulin-like growth factor II (IGF-II).

Method For Treating Diabetic Neuropathy With Ngf
view source
US Patent:

6440928, Aug 27, 2002
Filed:

Jan 8, 1998
Appl. No.:

09/004965
Inventors:

Douglas N. Ishii - LaPorte CO
Assignee:

Colorado State University Research Foundation - Fort Collins CO
International Classification:

C07K 3818
US Classification:

514 2, 514 3
Abstract:

Mammals suffering from diabetic neuropathy can be treated by a method involving administering to the mammal nerve growth factor (NGF) in an amount effective to ameliorate the diabetic neuropathic condition.

Method For Treating The Central Nervous System By Administration Of Igf Structural Analogs
view source
US Patent:

20060105946, May 18, 2006
Filed:

Aug 28, 2001
Appl. No.:

10/363574
Inventors:

Douglas Ishii - La Porte CO, US
International Classification:

A61K 38/30
US Classification:

514012000
Abstract:

This invention is directed to a method for treating a disease or disorder of the brain or spinal cord in a mammal, including human, comprising the administration of an effective amount of an insulin-like growth factor (IGF) structural analog at a site outside of the blood-brain, blood-central nervous system, or blood-spinal cord barrier.